Your submission is now a Draft.

Once it's ready, please submit your draft for review by our team of Community Moderators. Thank you!

You have been invited to co-author this question.

When it is ready, the author will submit it for review by Community Moderators. Thanks for helping!


This question now needs to be reviewed by Community Moderators.

We have high standards for question quality. We also favor questions on our core topic areas or that we otherwise judge valuable. We may not publish questions that are not a good fit.

If your question has not received attention within a week, or is otherwise pressing, you may request review by tagging @moderators in a comment.

You have been invited to co-author this question.

It now needs to be approved by Community Moderators. Thanks for helping!


{{qctrl.question.predictionCount() | abbrNumber}} predictions
{{"myPredictionLabel" | translate}}:  
{{ qctrl.question.resolutionString() }}
{{qctrl.question.predictionCount() | abbrNumber}} predictions
My score: {{qctrl.question.player_log_score | logScorePrecision}}
Created by: juancambeiro and
co-authors , {{coauthor.username}}

Make a Prediction


On 25 November, South Africa announced that it was tracking a new variant, B.1.1.529/Omicron, and shared the following:

  • New variant detected in South Africa (lineage B.1.1.529) with high number of mutations, which are concerning for predicted immune evasion and transmissibility
  • B.1.1.529 genomes produced from samples collected 12-20 Nov from Gauteng, SA (n=77), Botswana (n=4) and Hong Kong (n=1, traveler from SA)
  • B.1.1.529 can be detected by one particular PCR assay (before whole genome sequencing)
  • Early signs from diagnostic laboratories that B.1.1.529 has rapidly increased in Gauteng and may already be present in most provinces
  • Mutation profile predicted to give significant immune evasion and enhanced transmissibility

See also these three assessments by the UK HSA, Belgian NRL, and WHO respectively.

There is substantial concern that Omicron might be more transmissible than Delta.

One way to assess the transmissibility of a virus is to examine its basic reproduction number (R0), which Delamater et. al (2019) define as:

an epidemiologic metric used to describe the contagiousness or transmissibility of infectious agents. R0 is affected by numerous biological, sociobehavioral, and environmental factors that govern pathogen transmission and, therefore, is usually estimated with various types of complex mathematical models...R0 is not a biological constant for a pathogen, a rate over time, or a measure of disease severity, and R0 cannot be modified through vaccination campaigns. R0 is rarely measured directly, and modeled R0 values are dependent on model structures and assumptions.

Again, note that that R0 calculation refers to transmission in a theoretical population where no one is vaccinated and no one has already had the disease. This question is thus trying to forecast the inherent transmissibility of Omicron, irrespective of its ability to evade preexisting immunity.